Zusammenfassung
Die konservative Revaskularisation durch Thrombolytika oder Ballondilatation (PTCA) führt, als Teil des therapeutischen Effektes, zu einem instabilen Koronarsitus. Thrombolytika lösen zwar den Thrombozyten-Fibrin-Pfropf auf, beeinflussen aber den darunterliegenden rupturierten Plaque nicht, der zunächst die thrombosierende Kettenreaktion ausgelöst hat. Das Aufblähen des PTCA-Ballons bricht und zerreißt die durch den Plaque belegte Koronarintima und die Entblößung von frischem Kollagen ruft einen Entzündungsherd hervor. Um den Erfolg oder Mißerfolg der intrakoronar erfolgten Intervention durch Thrombolytika oder PTCA festzustellen, wird üblicherweise eine angiographische Untersuchung vorgenommen. Dieser primär anatomische Parameter ist jedoch nicht immer zuverlässig, und bei 2–30% der „erfolgreich“ dilatierten oder reperfundierten Patienten kann sich klinisch stumm oder auch symptomatisch die Interventionsstelle wieder verschließen, während die Patienten sich auf der Intensivstation erholen [1–11]. Auf diese Weise kann der Übergang des Koronarherdes von einem relativ stabilen in einen instabilen Zustand untersucht werden. Zusätzlich können patienten-und koronarsitusspezifische Daten für jeden einzelnen Patienten während des Ereignisses gesammelt werden, entweder während des Herzinfarktes bei der Einlieferung oder während des transitorischen Koronarverschlusses bei der PTCA. Dieses Referenzereignis kann eine weitere Einsicht in die Muster geben, die bei rezidivierender Instabilität vorliegen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Dorros G, Cowley MJ, Sinpson J, Bentivoglio LG, Block PC, Bourassa M, Detre K. Gossclin AJ, Gruntzig AR, Kelsey SF, Kent KM, Mock MB, Mullin SM, Myler RK, Passamani ER. Stcrtzer SH, Williams DO (1983) Percutaneous transluminal coronary angioplasty: report of complications from the National Heart. Lung, and Blood Institute PTCA Registry. Circulation 67: 723–730
Cowley M, Dorros G, Kelsey S, Raden M, Detre M (1984) Acute coronary events associated with percutaneous transluminal coronary angioplasty. Am J Cardiol 53: 12C - 16C
Bredlau CE, Roubin OS, Leimgruber PP, Douglas JS Jr., King SB III, Gruentzig AR (1985) In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty. Circulation 72: 1044–1052
Chesebro JH, Knatterud G, Roberts R, Borer J. Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P, Markis JE, Mueller H, Passamani ER, Powers ER, Rao AK, Robertson T, Ross A, Ryan TJ, Sobel BE, Willerson J, Williams DO, Zaret BL, Braunwald E (1987) Thrombolysis in myocardial infarction (TIM!) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 76: 142–154
Topol EJ, George BS, Kereiakes DJ, Candela RJ, Abbottsmith CW, Stump DC, Boswick JM, Stack RS, Califf RM, and the TAMI Study Group (1988) Comparison of two dose regimens of intravenous tissue plasminogen activator for acute myocardial infarction. Am J Cardiol 61: 723–728
Brower RW, Arnold AER, Lubsen J, Verstraete M, on behalf of the European Cooperative Study Group (1988) Coronary patency after intravenous infusion of recombinant tissue-type plasminogen activator in acute myocardial infarction. JACC 11: 681–688
Harrison DG, Ferguson DW, Collins SM, Skorton DJ, Ericksen EE, Kioschos JM, Marcus ML. White CW (1984) Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions. Circulation 69: 991–999
Gold HK, Leinback RC, Garabedian HD, Yasuda T, Johns JA, Grossbard EB, Palacios I. Collen D (1986) Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion. Circulation 73: 347–352
Hays U, Beller GA, Moore CA, Burwell LR. Craddock GB, Gascho JA. Smucker ML, Tedesco C, Nygaard TW (1988) Short-term infarct vessel patency with aspirin and dipyridamole started 24 to 36 hours after intravenous streptokinase. Am Heart Jill 115: 717–721
Schroder R. Neuhans KL, Linderer T. Leizorovicz A. Wegscheider K, Tebbe U for the ISAM study group (1987) Risk of death from recurrent ischemic events after intravenous streptokinase in acute myocardial infarction: results from the Intravenous Streptokinase in Myocardial Infarction (I SAM) study. Circulation 76 (suppl II): 44–51
Gash AK, Spann JF, Sherry S, Belber AD. Carabello BA, McDonough MT. Mann RH, McCann WE, Gault JH, Gentzler RD, Kent RL (1986) Factors influencing reocclusion after coronary thrombolysis for acute myocardial infarction. Am J Cardiol 57: 175–177
Stern S, Tzivoni D (1974) Early detection of silent ischemic heart disease by 24-hour electrocardiographic monitoring of active subjects. Br Heart J 36: 481–486
Deanfield JE, Selwyn AP, Chierchia S, Maseri A, Riberio P, Krikler S, Morgan M (1983) Myocardial ischaemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes. Lancet l: 753–758
Deanfield JE, Shea M, Ribiero P, de Landsheere CM, Wilson RA, Horlock P, Selwyn AP (1984) Transient ST-segment depression as a marker of myocardial ischemia during daily life. Am J Cardiol 54: 1195–1200
Schang SJ, Pepine CJ (1977) Transient asymptomatic ST segment depression during daily activity. Am J Cardiol 39: 396–402
Biagini A, Mazzei MG, Carpeggiani C, Testa R, Antonelli R, Michelassi C, L’Abbate A, Maseri A (1982) Vasospastic ischemic mechanism of frequent asymptomatic transient ST-T changes during continuous electrocardiographic monitoring in selected unstable angina patients. Am Heart J 103: 13–19
Imperi GA, Lambert CR, Coy K, Lopez L, Pepine CJ (1987) Effects of titrated beta blockade (metoprolol) on silent myocardial ischemia in ambulatory patients with coronary artery disease. Am J Cardiol 60: 519–524
Krucoff MW, Green CE, Satler LF, Miller FC, Pallas RS, Kent KM, Del Negro AA, Pearle DL, Fletcher RD, Rackley CE (1986) Noninvasive detection of coronary artery patency using continuous ST-segment monitoring. Am J Cardiol 57: 916–922
Davies GJ, Chierchia S, Maseri A (1984) Prevention of myocardial infarction by very early treatment with intracoronary streptokinase: some clinical observations. N Engl J Med 311: 1488–1492
Krucoff MW, Pope JE, Bottner RK, Renzi RH, Wagner GS, Kent KM (1987) Computer-Assisted ST-segment Monitoring: Experience During and after brief coronary occlusion. J Electrocardiology Suppl 15–21
Krucoff MW, Akbari MM, Stark KS, Ahmed SW, Parente AR, Renzi RH, Kent KM. Pitfalls of 1 and 2 lead ST segment recording of silent or sysmptomatic ischemia. Circulation (abstr), in press
Krucoff, MW (1988) Identification of high-risk patients with silent myocardial ischemia after percutaneous transluminal coronary angioplasty by multilead monitoring. Am J Cardiol 61: 29F - 34F
Krucoff MW, Pope JE, Bottner RK, Adams IM, Wagner GS, Kent KM (1987) “Dedicated ST-segment monitoring in the CCU after successful coronary angioplasty: incidence and prognosis of silent and symptomatic ischemia” in Silent Ischemia, von Arnim Th, Maseri A eds., Steinkopff Verlag, Darmstadt, p. 140–146
Krucoff MW, Parente AR, Bottner RK, Renzi RH, Stark KS, Shugoll RA, Ahmed SW, De-Michele J, Stroming SL, Green CE, Rackley CE, Kent KM (1988) Stability of multilead ST-segment “fingerprints” over time after percutaneous transluminal coronary angioplasty and its usefulness in detecting reocclusion. Am J Cardiol 61: 1232–1237
Adams IM, Mortara DW (1987) “A new method for electrocardiographic monitoring” in Acute Coronary Care 1987, Califf RM and Wagner GS eds., Martinus Nijhoff, Boston 1987, p. 165–176
Severi S, Marraccini P, Michelassi C, Orsini E, Nassisi V, L’Abbate A (1988) Electrocardiographic manifestations and in-hospital prognosis of transient acute myocardial ischemia at rest. Am J Cardiol 61: 31–37
Johnson SM, Mauritson DR, Winiford MD, Willerson JT, Firth BG, Cary JR, Hillis LD (1982) Continuous electrocardiographic monitoring in patients with unstable angina pectoris: identification of high-risk subgroup with severe coronary disease, variant angina, and/or impaired early prognosis. Am Heart J 103: 4–12
Gottlieb SO, Weisfeldt ML, Ouyang P (1986) Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N Engl J Med 314: 1214–1219
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Krucoff, M.W., Jackson, Y.R., Stark, K.S., Kent, K.M. (1989). Elektrokardiographische Muster eines drohenden, unabhängig von instabiler pektanginöser Symptomatik auftretenden Koronarverschlusses. In: v. Arnim, T., Maseri, A. (eds) Prädisponierende Bedingungen für akute Ischämiesyndrome. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-662-12731-5_11
Download citation
DOI: https://doi.org/10.1007/978-3-662-12731-5_11
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-7985-0819-4
Online ISBN: 978-3-662-12731-5
eBook Packages: Springer Book Archive